Publication | Closed Access

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

OncologyAdult PatientsMetronomic TherapyClinical TrialsMetastatic OsteosarcomaPharmacotherapyCancer TreatmentMedicineRadiation OncologyOrthopaedic SurgeryHealth Sciences